Evidence map›Paper›PMID 37539750›Full record

ArticleStem cells (Dayton, Ohio)2023

Uncovering the Heterogeneity of Cardiac Lin-KIT+ Cells: A scRNA-seq Study on the Identification of Subpopulations.

Yan Shen, Il-Man Kim, Yaoliang Tang

Open access · greenAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yan ShenDepartment of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Il-Man KimDepartment of Anatomy, Cell Biology and Physiology, School of Medicine, Indiana University, Indianapolis, IN, USA.
Yaoliang TangDepartment of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.ORCID 0000-0002-8372-1545
Augusta University · USIndiana University – Purdue University Indianapolis · US

Funding

Epigenetic reprogramming of cardiac myofibroblasts for cardiac repairR01HL169964 · NHLBI · AUGUSTA UNIVERSITY · PI YAO LIANG TANG · 2023 to 2026
$2.0M
Identifying novel pathways targeting endothelial-to-mesenchymal transition during heart failureR01HL146481 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI KIM, IL-MAN · 2019 to 2022
$1.6M
American Heart Association-American Stroke Association 964856NHLBI NIH HHS R01 HL146481NHLBI NIH HHS R01 HL169964
6 · The paper itself

Abstract

The reparative potential of cardiac Lin-KIT+ (KIT) cells is influenced by their population, but identifying their markers is challenging due to changes in phenotype during in vitro culture. Resolving this issue requires uncovering cell heterogeneity and discovering new subpopulations. Single-cell RNA sequencing (scRNA-seq) can identify KIT cell subpopulations, their markers, and signaling pathways. We used 10× genomic scRNA-seq to analyze cardiac-derived cells from adult mice and found 3 primary KIT cell populations: KIT1, characterized by high-KIT expression (KITHI), represents a population of cardiac endothelial cells; KIT2, which has low-KIT expression (KITLO), expresses transcription factors such as KLF4, MYC, and GATA6, as well as genes involved in the regulation of angiogenic cytokines; KIT3, with moderate KIT expression (KITMOD), expresses the cardiac transcription factor MEF2C and mesenchymal cell markers such as ENG. Cell-cell communication network analysis predicted the presence of the 3 KIT clusters as signal senders and receivers, including VEGF, CXCL, and BMP signaling. Metabolic analysis showed that KIT1 has the low activity of glycolysis and oxidative phosphorylation (OXPHOS), KIT2 has high glycolytic activity, and KIT3 has high OXPHOS and fatty acid degradation activity, indicating distinct metabolic adaptations of the 3 KIT populations. Through the systemic infusion of KIT1 cells in a mouse model of myocardial infarction, we observed their involvement in promoting the formation of new micro-vessels. In addition, in vitro spheroid culture experiments demonstrated the cardiac differentiation capacity of KIT2 cells.

Indexed as

Endothelial CellsSingle-Cell Gene Expression AnalysisAnimalsCell DifferentiationGene Expression RegulationHeartMiceTranscription FactorsTranscription Factorscardiac KIT cellscell-cell communicationmetabolismsingle-cell RNA sequencingspheroid

Identifiers

PMID37539750
PMCPMC11009691
OpenAlexW4385563715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.